Commentary: Finding the correct inhaled corticosteroid dose in asthma

Postgraduate Medicine

Volumn 117, Issue 5, 2005, Pages 21-24

  Graft, David F ^a,b  

^a PARK NICOLLET CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; SALMETEROL XINAFOATE; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT;

ADRENAL SUPPRESSION; ASTHMA; CATARACT; CONFERENCE PAPER; DISEASE EXACERBATION; GROWTH RETARDATION; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; LUNG FUNCTION; PEAK EXPIRATORY FLOW; SIDE EFFECT; SPIROMETRY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; FORCED EXPIRATORY VOLUME; INHALATIONAL DRUG ADMINISTRATION; MEDICAL SOCIETY; REVIEW; UNITED STATES;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FORCED EXPIRATORY VOLUME; HUMANS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 20844438174     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2005.05.1626     Document Type: Conference Paper

References (9)

1. National Asthma Education and Prevention Program expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda: US Dept of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, 1997; NIH publication 97-4051. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed Feb 25, 2005
2. National Asthma Education and Prevention Program expert panel report: guidelines for the diagnosis and management of asthma - update on selected topics 2002. Bethesda: US Dept of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, 2002; NIH publication 02-5075. Available at: http://nhlbi.nih.gov/guidelines/asthma/execsumm.pdf, Accessed Feb 25, 2005
3. Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343(5):332-6
4. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995; 332(13):868-75
5. British guidelines on the management of asthma: a national clinical guideline. Rev. London: British Thoracic Society and Scottish Intercollegiate Guidelines Network, 2004. Available at: http://www.brit-thoracic.org.uk/docs/ asthmafull.pdf. Accessed Mar 15, 2005
6. Powell H, Gibson PG. High dose versus low dose inhaled corticostetoid as initial starting dose for asthma in adults and children. Cochrane Database Syst. Rev 2004;2:CD004109
7. Pedersen S, O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 1997;52(39 Suppl):1-34
8. Masoli M, Holt S, Weatherall M, et al. The dose-response relationship of inhaled corticosteroids in asthma. Curr Allergy Asthma Rep 2004;4(2):144-8
9. Holt S, Suder A, Weatherall M, et al. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ 2001;323(7307):253-6